iSatori Technologies, LLC – Trademark Portfolio
Entity Type: 16
iSatori Technologies, LLC holds 17 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 12 filings in this category. The portfolio also extends into Class 32 (Light Beverages) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include MORPH. The owner is based in Golden, CO.
15000 W. 6th Avenue Suite 202
Golden, CO 80401
Showing of trademarks Trademarks
Trademark Classifications
iSatori Technologies, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does iSatori Technologies, LLC have?
iSatori Technologies, LLC has 17 U.S. trademarks filed with the USPTO. Of these, 1 registered, 8 abandoned, 8 cancelled.
What trademark classes does iSatori Technologies, LLC file in?
iSatori Technologies, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 32 (Light Beverages), Class 41 (Education & Entertainment). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are iSatori Technologies, LLC's most well-known trademarks?
iSatori Technologies, LLC's registered trademark portfolio includes well-known marks such as MORPH. These are among 1 currently registered trademark in the portfolio.
What is iSatori Technologies, LLC's trademark registration success rate?
iSatori Technologies, LLC has a 6% trademark registration rate, with 1 out of 17 resolved applications resulting in successful registration. Currently, 0 applications are pending review.